Cargando…
An impact of lipid profile and lipid lowering drugs on ≥70 year olds of an upper socioeconomic class: a retrospective cohort study
BACKGROUND: Life expectancy has greatly increased, generating an improvement in screening programs for disease prevention, lifesaving drugs and medical devices. The impact of lowering low-density lipoprotein cholesterol (LDL-C) in the very elderly is not well-established. Our aim was to explore the...
Autores principales: | Eden Friedman, Yehudit, Steinberg, David M., Canetti, Michal, Cohen, Ido, Segev, Shlomo, Salomon, Ophira |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8480056/ https://www.ncbi.nlm.nih.gov/pubmed/34587967 http://dx.doi.org/10.1186/s12944-021-01529-2 |
Ejemplares similares
-
Lipid-lowering pharmacotherapy and socioeconomic status: atherosclerosis risk in communities (ARIC) surveillance study
por: Kitzmiller, Joseph P, et al.
Publicado: (2013) -
Potential contribution of lifestyle and socioeconomic factors to healthy user bias in antihypertensives and lipid-lowering drugs
por: Kinjo, Mitsuyo, et al.
Publicado: (2017) -
Lipid-lowering and kidney
por: Lee, Sang-Hak
Publicado: (2023) -
Crosstalk between purinergic receptors and lipid mediators in leishmaniasis
por: Chaves, Mariana M., et al.
Publicado: (2016) -
Impact of Socioeconomic Factors and Gender on Refill Adherence and Persistence to Lipid-Lowering Therapy in Type 1 Diabetes
por: Hero, Christel, et al.
Publicado: (2021)